Metabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System

2-arylbenzofurans represent a small group of bioactive compounds found in the plant family Moraceae. As it has not been investigated whether these substances are stable during passage through the gastrointestinal tract, their biological effects may be altered by the metabolism of intestinal microbio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ondrej Vesely, Petr Marsik, Veronika Jarosova, Ivo Doskocil, Karel Smejkal, Pavel Kloucek, Jaroslav Havlik
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/f4ca026d48844cb2ac1d365fba1e5b54
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f4ca026d48844cb2ac1d365fba1e5b54
record_format dspace
spelling oai:doaj.org-article:f4ca026d48844cb2ac1d365fba1e5b542021-11-25T17:35:16ZMetabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System10.3390/foods101127542304-8158https://doaj.org/article/f4ca026d48844cb2ac1d365fba1e5b542021-11-01T00:00:00Zhttps://www.mdpi.com/2304-8158/10/11/2754https://doaj.org/toc/2304-81582-arylbenzofurans represent a small group of bioactive compounds found in the plant family Moraceae. As it has not been investigated whether these substances are stable during passage through the gastrointestinal tract, their biological effects may be altered by the metabolism of intestinal microbiota or cells. The aim of the present study was to investigate and compare mulberrofuran Y (<b>1</b>), moracin C (<b>2</b>), and mulberrofuran G (<b>3</b>) in an in vitro model of human intestinal bacterial fermentation and in an epithelial model using the Caco-2 cell line. The analysis of compounds by LC-MS-Q-TOF showed sufficient stability in the fermentation model, with no bacterial metabolites detected. However, great differences in the quantity of permeation were observed in the permeability assay. Moreover, mulberrofuran Y (<b>1</b>) and moracin C (<b>2</b>) were observed to be transformed into polar metabolites by conjugation. Among the test compounds, mulberrofuran Y (<b>1</b>) was mostly stable and accumulated in endothelial cells (85.3%) compared with mulberrofuran G (<b>3</b>) and moracin C (<b>2</b>) (14% and 8.2%, respectively). Thus, only a small amount of mulberrofuran Y (<b>1</b>) was conjugated. Moracin C (<b>2</b>) and mulberrofuran G (<b>3</b>) were metabolized almost completely, with only traces of the unchanged molecule being found on the apical and cellular sides of the system. Only conjugates of mulberrofuran Y (<b>1</b>) and moracin C (<b>2</b>) were able to reach the basolateral side. Our results provide the basic description of bioavailability of these three compounds, which is a necessary characteristic for final evaluation of bio-efficacy.Ondrej VeselyPetr MarsikVeronika JarosovaIvo DoskocilKarel SmejkalPavel KloucekJaroslav HavlikMDPI AGarticlemoracin Cmulberrofuran Gmulberrofuran Ypermeability assayCaco-2 cellsintestinal fermentationChemical technologyTP1-1185ENFoods, Vol 10, Iss 2754, p 2754 (2021)
institution DOAJ
collection DOAJ
language EN
topic moracin C
mulberrofuran G
mulberrofuran Y
permeability assay
Caco-2 cells
intestinal fermentation
Chemical technology
TP1-1185
spellingShingle moracin C
mulberrofuran G
mulberrofuran Y
permeability assay
Caco-2 cells
intestinal fermentation
Chemical technology
TP1-1185
Ondrej Vesely
Petr Marsik
Veronika Jarosova
Ivo Doskocil
Karel Smejkal
Pavel Kloucek
Jaroslav Havlik
Metabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System
description 2-arylbenzofurans represent a small group of bioactive compounds found in the plant family Moraceae. As it has not been investigated whether these substances are stable during passage through the gastrointestinal tract, their biological effects may be altered by the metabolism of intestinal microbiota or cells. The aim of the present study was to investigate and compare mulberrofuran Y (<b>1</b>), moracin C (<b>2</b>), and mulberrofuran G (<b>3</b>) in an in vitro model of human intestinal bacterial fermentation and in an epithelial model using the Caco-2 cell line. The analysis of compounds by LC-MS-Q-TOF showed sufficient stability in the fermentation model, with no bacterial metabolites detected. However, great differences in the quantity of permeation were observed in the permeability assay. Moreover, mulberrofuran Y (<b>1</b>) and moracin C (<b>2</b>) were observed to be transformed into polar metabolites by conjugation. Among the test compounds, mulberrofuran Y (<b>1</b>) was mostly stable and accumulated in endothelial cells (85.3%) compared with mulberrofuran G (<b>3</b>) and moracin C (<b>2</b>) (14% and 8.2%, respectively). Thus, only a small amount of mulberrofuran Y (<b>1</b>) was conjugated. Moracin C (<b>2</b>) and mulberrofuran G (<b>3</b>) were metabolized almost completely, with only traces of the unchanged molecule being found on the apical and cellular sides of the system. Only conjugates of mulberrofuran Y (<b>1</b>) and moracin C (<b>2</b>) were able to reach the basolateral side. Our results provide the basic description of bioavailability of these three compounds, which is a necessary characteristic for final evaluation of bio-efficacy.
format article
author Ondrej Vesely
Petr Marsik
Veronika Jarosova
Ivo Doskocil
Karel Smejkal
Pavel Kloucek
Jaroslav Havlik
author_facet Ondrej Vesely
Petr Marsik
Veronika Jarosova
Ivo Doskocil
Karel Smejkal
Pavel Kloucek
Jaroslav Havlik
author_sort Ondrej Vesely
title Metabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System
title_short Metabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System
title_full Metabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System
title_fullStr Metabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System
title_full_unstemmed Metabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System
title_sort metabolism of selected 2-arylbenzofurans in a colon in vitro model system
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/f4ca026d48844cb2ac1d365fba1e5b54
work_keys_str_mv AT ondrejvesely metabolismofselected2arylbenzofuransinacoloninvitromodelsystem
AT petrmarsik metabolismofselected2arylbenzofuransinacoloninvitromodelsystem
AT veronikajarosova metabolismofselected2arylbenzofuransinacoloninvitromodelsystem
AT ivodoskocil metabolismofselected2arylbenzofuransinacoloninvitromodelsystem
AT karelsmejkal metabolismofselected2arylbenzofuransinacoloninvitromodelsystem
AT pavelkloucek metabolismofselected2arylbenzofuransinacoloninvitromodelsystem
AT jaroslavhavlik metabolismofselected2arylbenzofuransinacoloninvitromodelsystem
_version_ 1718412202435674112